You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 274 No. 20, November 22, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contributions
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Race, Treatment, and Long-term Survival From Prostate Cancer in an Equal-Access Medical Care Delivery System

Scott A. Optenberg, DrPH; Ian M. Thompson, MD; Paul Friedrichs, MD; Barbara Wojcik, PhD; Catherine R. Stein, MS; Barnett Kramer, MD

JAMA. 1995;274(20):1599-1605.


Abstract

Objective.
—To evaluate long-term survival of black and white prostate cancer patients in an equal-access medical care system to help distinguish biological from medical and social explanations of mortality differences.

Design and Setting.
—Retrospective study of US Department of Defense tumor registry patients with prostate cancer. Ethnicity, age, diagnosis, staging, risk factors, treatment, and survival end points were extracted.

Patients.
—Prostate cancer patients (N=1606; 7.5% black, 92.5% white) who were active-duty personnel, dependents, or retirees eligible for care in the military medical system.

Main Outcome Measures.
—Racial differences in tumor stage and grade, risk factors, recurrence, and treatment wait time (time between initial diagnosis and initial treatment); influence of stage, grade, treatment, wait time, age, and race on survival.

Results.
—No differences were found in behavioral risk factors or tumor grade or size, but blacks entered active treatment (P<.001) and exhibited a higher relative risk of cancer (P=.01) in younger age groups, presented with higher stage (P<.001), and demonstrated increased progression in distant metastatic disease (P=.01). No significant differences were detected in overall wait time. When adjusted for stage, no difference was found in type of treatment. Overall, stage, grade, and age were found to affect survival (P=.04 to P<.001), but race did not. When analyzed by stage, blacks demonstrated a clear trend of longer survival for distant metastatic disease (P=.04 to P=.06). This trend was confirmed using Kaplan-Meier estimates (P=.04, likelihood ratio).

Conclusions.
—This analysis suggests that in an equal-access medical care system there are no stage-specific differences in treatment between black and white prostate cancer patients. Survival among blacks is similar to that among whites and may surpass it for high-stage disease.

(JAMA. 1995;274:1599-1605)



Author Affiliations

From the Center for Healthcare Education and Studies, US Army Medical Department Center and School (Drs Optenberg and Wojcik and Ms Stein), and Urology Service, Brooke Army Medical Center (Drs Friedrichs and Thompson), San Antonio, Tex; and Division of Cancer Prevention and Control, National Cancer Institute, Bethesda, Md (Dr Kramer).


Footnotes

The opinions expressed herein are those of the authors and do not necessarily reflect those of the US Departments of the Army and Defense or the National Cancer Institute.

Reprint requests to Center for Healthcare Education and Studies, Academy of Health Sciences, US Army, 1608 Stanley Rd, Bldg 2268, Fort Sam Houston, TX 78234-6125 (Dr Optenberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Heeding Our Words: Complexities of Research Among Low-Literacy Populations
Simon et al.
JCO 2009;27:1938-1940.
FULL TEXT  

Explaining the Race Difference in Prostate Cancer Stage at Diagnosis
Jones et al.
Cancer Epidemiol. Biomarkers Prev. 2008;17:2825-2834.
ABSTRACT | FULL TEXT  

Racial Differences in the Evaluation and Treatment of Hepatitis C Among Veterans: A Retrospective Cohort Study
Rousseau et al.
AJPH 2008;98:846-852.
ABSTRACT | FULL TEXT  

Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004
Robbins et al.
Am J Epidemiol 2007;166:71-78.
ABSTRACT | FULL TEXT  

Ethnic differences among patients with cutaneous melanoma.
Cormier et al.
Arch Intern Med 2006;166:1907-1914.
ABSTRACT | FULL TEXT  

Information Desired and Acquired by Men With Prostate Cancer: Data From Ethnic Focus Groups
Maliski et al.
Health Educ Behav 2006;33:393-409.
ABSTRACT  

Racial Differences in Screening for Prostate Cancer in the Elderly
Gilligan et al.
Arch Intern Med 2004;164:1858-1864.
ABSTRACT | FULL TEXT  

Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer
Godley et al.
JNCI J Natl Cancer Inst 2003;95:1702-1710.
ABSTRACT | FULL TEXT  

Cancer Survival in Kentucky and Health Insurance Coverage
McDavid et al.
Arch Intern Med 2003;163:2135-2144.
ABSTRACT | FULL TEXT  

Determinants of Mortality Following a Diagnosis of Prostate Cancer in Veterans Affairs and Private Sector Health Care Systems
Freeman et al.
AJPH 2003;93:1706-1712.
ABSTRACT | FULL TEXT  

Stage at Diagnosis and Survival in a Multiethnic Cohort of Prostate Cancer Patients
Oakley-Girvan et al.
AJPH 2003;93:1753-1759.
ABSTRACT | FULL TEXT  

Some Perspective on Black-White Cancer Statistics
Brawley
CA Cancer J Clin 2002;52:322-325.
FULL TEXT  

Effect of Race on Biochemical Disease-free Outcome in Patients with Prostate Cancer Treated with Definitive Radiation Therapy in an Equal-Access Health Care System: Radiation Oncology Report of the Department of Defense Center for Prostate Disease Research
Johnstone et al.
Radiology 2002;225:420-426.
ABSTRACT | FULL TEXT  

Cancer Survival Among US Whites and Minorities: A SEER (Surveillance, Epidemiology, and End Results) Program Population-Based Study
Clegg et al.
Arch Intern Med 2002;162:1985-1993.
ABSTRACT | FULL TEXT  

Addressing Racial And Ethnic Barriers To Effective Health Care: The Need For Better Data
Bierman et al.
Health Aff (Millwood) 2002;21:91-102.
ABSTRACT | FULL TEXT  

Survival of Blacks and Whites After a Cancer Diagnosis
Bach et al.
JAMA 2002;287:2106-2113.
ABSTRACT | FULL TEXT  

Racial and Ethnic Disparities in the Receipt of Cancer Treatment
Shavers and Brown
JNCI J Natl Cancer Inst 2002;94:334-357.
ABSTRACT | FULL TEXT  

Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study
Hoffman et al.
JNCI J Natl Cancer Inst 2001;93:388-395.
ABSTRACT | FULL TEXT  

Association of African-American Ethnic Background With Survival in Men With Metastatic Prostate Cancer
Thompson et al.
JNCI J Natl Cancer Inst 2001;93:219-225.
ABSTRACT | FULL TEXT  

Equivalent Racial Outcome After Conformal Radiotherapy for Prostate Cancer: A Single Departmental Experience
Connell et al.
JCO 2001;19:54-61.
ABSTRACT | FULL TEXT  

Racial and Ethnic Differences in Access to Medical Care
Mayberry et al.
Med Care Res Rev 2000;57:108-145.
ABSTRACT  

Race and Outcomes: Is This the End of the Beginning for Minority Health Research?
Brawley and Freeman
JNCI J Natl Cancer Inst 1999;91:1908-1909.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.